Metabolome and Gut Microbiome Changes During Smoking Cessation in Long-term Drug Therapy in a Therapeutic Community
A legfontosabb adatok
- Ki végzi
- Sigmund Freud PrivatUniversitat
- Hol
- Ausztria3 helyszín, 1 országbanVálassz országot a helyszínekhez
- Azonosító
- Állapot
- Befejeződött
- Résztvevők
- 97 fő vett részt
- Kezdés
- 2025. máj. 5.
- Befejezés
- 2026. szept. 18.
- A vizsgálat típusa
- Beavatkozással járó, 3 csoportAz egyik csoport egy már használt kezelést kap, összehasonlításként.
- A vizsgált kezelések
- 6-weeks CBT smoking cessation programme
- Long-term drug therapy within a therapeutic community
- A regiszteradat frissítve
- 2026. szeptember 29.
Ki vehet részt
- Életkor
- 18 év felett
- Nem
- Nők és férfiak
- Egészséges önkéntesek
- Részt vehetnek
A regiszter feltételei, szó szerint
Mind a 17 feltétel megnézéseKevesebb
Ki vehet részt
- diagnosis of a form of substance use disorder (F1x.x) by a licensed psychiatrist according to ICD-10
- minimum age of 18 years
- sufficient knowledge of the German language
- willingness to quit smoking
- willingness and ability to consent
- minimum age of 18 years
- sufficient knowledge of the German language
- willingness and ability to consent
Ki nem vehet részt
- severe mental or organic illnesses (such as epilepsy, brain tumors, recent major surgery), tumor diseases, dementia (Mini Mental Score <20), severe autoimmune diseases or immunosuppression, acute infections, or acute diarrhea, prior gastrointestinal surgery (except appendectomy)
- prior participation in a smoking cessation programme
- cardiovascular disease
- age below 18,
- lack of consent, inability to provide informed consent
- acute psychotic symptoms or acute suicidal tendencies
- pregnancy or breastfeeding
- probiotic intake within the last 6 months,
- ongoing consumtion of dietary supplements, probiotics, antibiotics, or prebiotic supplements during the study
Ennek a vizsgálatnak nincs helyszíne itt: Egyesült Államok.
Egy országban van helyszíne. Válassz országot, hogy lásd a helyszíneket.
A vizsgálatról
Mit akar kideríteni a vizsgálat
Theoretical Framework: Cigarette smoking is the leading preventable cause of death worldwide, with nicotine dependence notably common among individuals with Substance Use Disorders (SUD). Smoking exacerbates both physical and mental health issues, further complicating the treatment of SUD. Current therapeutic approaches for SUD often prove inadequate, indicating a need for new strategies. Recent advancements in metabolomics and gut microbiome research have provided valuable insights into the biological mechanisms underlying addiction.
A teljes eredeti leírásKevesebb
Objectives: This study aims to investigate the therapeutic potential of smoking cessation for individuals with SUD, using a six-week intervention within a therapeutic community. The research specifically explores the psychobehavioral, metabolic, and gut microbiome domains. It is hypothesized that smoking cessation will improve emotional regulation, self-efficacy, and reduce substance craving, mediated by changes in metabolic and microbiome profiles linked to brain reward systems.
Methods: A randomized controlled trial (N=150) will be conducted, examining outcomes such as clinical relapse rates, microbial and metabolic markers, particularly in choline and folate metabolism. Participants with SUD (n=100) will undergo a six-week smoking cessation intervention, with pre- and post-assessments, compared to a control group receiving treatment as usual. Metabolomic and microbiome analyses will be conducted using blood and stool samples, alongside psychological assessments via questionnaires. Assessments on a behavioural level will take place at a 3-months follow-up.
A cross-sectional, non-interventional healthy control group (n=50) will be examined at a single timepoint with an anologous panel of psychological variables, blood and stool to ascertain differences between smokers with SUD and healthy controls.
A vizsgálat 3 csoportja
- Treatment As UsualMár használt kezelés, összehasonlításként
Patients in the TAU group receive long-term rehabilitation drug treatment according to the 'community as a treatment'-model
Kezelés: Long-term drug therapy within a therapeutic community
- 6-weeks smoking cessation cognitive-behavioral therapy interventionA vizsgált kezelés
The "smoke free in 6 weeks" program is a standardized behavioural therapy intervention that takes place once a week for 1.5 hours over 6 weeks and is provided by the Austrian health insurance provider Österreichische Gesundheitskasse (ÖGK).
Kezelés: 6-weeks CBT smoking cessation programme és Long-term drug therapy within a therapeutic community
- Healthy controlsNincs vizsgálati kezelés, összehasonlításként
Control group with n=50 healthy adult subjects, examined at a single timepoint. No interventions will be administered in this arm.
Adatok és források
- Regiszteradat
- Szerepel a ClinicalTrials.gov-on.
- Hivatalos cím
- Metabolomic and Gut Microbial Biomarkers of Smoking Cessation Treatment in Long-term Drug Therapy: A Randomized Controlled Trial
- Publikációk
- A regiszteradat frissítve
- 2026. szeptember 29.